Life Sciences on the Rise: 2021 North American Report

30 Largest Transactions: Private Equity and Public Offerings

While the number of transactions and total amount raised in the private equity market eclipses that of the public market, the largest transactions have tended to be public offerings, with all four of the deals raising more than $1 billion. All but one of the largest 30 transactions occurred in regions covered by this report.

COMPANY NAME

SIZE MM DATE

TYPE CUSHMAN & WAKEFIELD MARKET

Royalty Pharma

$2,180

Jun 2020 Public New York City

Pharmaceutical Product Development Maravai Life Sciences

$1,863

Feb 2020 Public Other

$1,620

Nov 2020 Public San Diego

Moderna Therapeutics

$1,338

May 2020 Public Boston

Resilience

$755

Oct 2020 VC

San Diego

Certara

$668

Dec 2020 Public New Jersey

Sana Biotechnology

$588

Feb 2021

Public Seattle

EQRx

$570

Jan 2021

VC

Boston

MyoKardia

$551

May 2020 Public San Francisco Bay Area

Catalent

$548

Jun 2020 Public New Jersey

ElevateBio

$525

Mar 2021

VC

Boston

Iovance Biotherapeutics $525

May 2020 Public San Francisco Bay Area

10x Genomics

$506

Sep 2020 Public San Francisco Bay Area

Indigo Agriculture

$500

Jun 2020 VC

Boston

Insulet

$500

May 2020 Public Boston

Bluebird Bio

$500

May 2020 Public Boston

Lyell

$493

Mar 2020 VC

San Francisco Bay Area

AbCellera

$483

Dec 2020 Public Vancouver

Everest Medicines

$451

Oct 2020 Public New York City

Recursion

$436

Apr 2021

Public Salt Lake City

Legend Biotech

$424

Jun 2020 Public New Jersey

Immunomedics

$420

Apr 2020 Public New Jersey

Relay Therapeutics

$400

Jul 2020 Public Boston

GRAIL

$390

May 2020 VC

San Francisco Bay Area

Instil Bio

$368

Mar 2021

Public Dallas

Jul 2020 VC

San Francisco Bay Area

Zymergen

$350

RBNC Therapeutics

$340

Sep 2020 VC

San Francisco Bay Area

Adagio Therapeutics

$336

Apr 2021

VC

Boston

Schrödinger

$330

Aug 2020 Public New York City

Blueprint Medicines

$325

Jan 2020 Public Boston

8 / CUSHMAN & WAKEFIELD